Medical Imaging Corporation (TPEX:6637)
Taiwan · Delayed Price · Currency is TWD 74.00
-1.70 (-2.25%)
At close: Feb 11, 2026
Medical Imaging Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,125 | 829.03 | 682.18 | 487.29 | 604.12 | 545.92 | |
Revenue Growth (YoY) | 31.13% | 21.52% | 40.00% | -19.34% | 10.66% | 8.04% |
Cost of Revenue | 771.54 | 492.93 | 353.86 | 247.79 | 377.02 | 326.4 |
Gross Profit | 353.4 | 336.09 | 328.32 | 239.51 | 227.1 | 219.51 |
Selling, General & Admin | 131.79 | 136.46 | 116.41 | 93.06 | 92.23 | 90.48 |
Operating Expenses | 131.84 | 136.42 | 116.66 | 93.11 | 92.36 | 90.46 |
Operating Income | 221.56 | 199.67 | 211.66 | 146.4 | 134.75 | 129.05 |
Interest Expense | -5.35 | -2.64 | -2.78 | -3.38 | -3.69 | -3.43 |
Interest & Investment Income | 9.65 | 5.24 | 2.13 | 2.18 | 2.8 | 3.72 |
Earnings From Equity Investments | - | - | - | 6.66 | -30.71 | -9.19 |
Currency Exchange Gain (Loss) | 1.58 | 0.48 | -0.01 | 1.66 | -0.08 | -1.73 |
Other Non Operating Income (Expenses) | 0.45 | -0.72 | -0.2 | -0.12 | -0.95 | -0.09 |
EBT Excluding Unusual Items | 227.89 | 202.04 | 210.8 | 153.39 | 102.12 | 118.35 |
Gain (Loss) on Sale of Investments | -5.62 | -1.99 | -43.06 | -10.12 | -5.68 | - |
Gain (Loss) on Sale of Assets | 11.94 | 8.33 | 0.75 | 1.24 | 1.65 | 1.71 |
Other Unusual Items | - | - | - | - | - | 3.06 |
Pretax Income | 234.22 | 208.38 | 168.49 | 144.5 | 98.09 | 123.12 |
Income Tax Expense | 44.07 | 43.36 | 47.15 | 32.9 | 21.32 | 27.06 |
Net Income | 190.14 | 165.02 | 121.34 | 111.6 | 76.78 | 96.06 |
Net Income to Common | 190.14 | 165.02 | 121.34 | 111.6 | 76.78 | 96.06 |
Net Income Growth | 35.56% | 36.00% | 8.72% | 45.36% | -20.07% | -3.74% |
Shares Outstanding (Basic) | 25 | 23 | 21 | 21 | 21 | 21 |
Shares Outstanding (Diluted) | 25 | 23 | 22 | 22 | 22 | 21 |
Shares Change (YoY) | 13.30% | 7.38% | -0.07% | -0.01% | 0.12% | -0.10% |
EPS (Basic) | 7.53 | 7.17 | 5.66 | 5.20 | 3.58 | 4.48 |
EPS (Diluted) | 7.50 | 7.15 | 5.64 | 5.19 | 3.57 | 4.46 |
EPS Growth | 19.69% | 26.77% | 8.67% | 45.38% | -19.96% | -3.88% |
Free Cash Flow | -268.08 | 172.14 | 88.64 | 211.02 | 81.99 | 70.85 |
Free Cash Flow Per Share | -10.58 | 7.46 | 4.12 | 9.80 | 3.81 | 3.30 |
Dividend Per Share | 4.000 | 4.000 | 3.000 | 2.800 | 2.000 | 2.500 |
Dividend Growth | 33.33% | 33.33% | 7.14% | 40.00% | -20.00% | - |
Gross Margin | 31.41% | 40.54% | 48.13% | 49.15% | 37.59% | 40.21% |
Operating Margin | 19.70% | 24.09% | 31.03% | 30.04% | 22.30% | 23.64% |
Profit Margin | 16.90% | 19.91% | 17.79% | 22.90% | 12.71% | 17.60% |
Free Cash Flow Margin | -23.83% | 20.76% | 12.99% | 43.30% | 13.57% | 12.98% |
EBITDA | 270.29 | 248.76 | 252.56 | 197.45 | 188.89 | 178.06 |
EBITDA Margin | 24.03% | 30.01% | 37.02% | 40.52% | 31.27% | 32.62% |
D&A For EBITDA | 48.72 | 49.09 | 40.9 | 51.05 | 54.15 | 49.01 |
EBIT | 221.56 | 199.67 | 211.66 | 146.4 | 134.75 | 129.05 |
EBIT Margin | 19.70% | 24.09% | 31.03% | 30.04% | 22.30% | 23.64% |
Effective Tax Rate | 18.82% | 20.81% | 27.98% | 22.77% | 21.73% | 21.98% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.